Sirona Biochem (TSXV:SBM) Scaled Net Operating Assets : -0.54 (As of Jan. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Sirona Biochem Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sirona Biochem's operating assets for the quarter that ended in Jan. 2024 was C$0.59 Mil. Sirona Biochem's operating liabilities for the quarter that ended in Jan. 2024 was C$1.15 Mil. Sirona Biochem's Total Assets for the quarter that ended in Oct. 2023 was C$1.03 Mil. Therefore, Sirona Biochem's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2024 was -0.54.

Sirona Biochem Scaled Net Operating Assets Historical Data

The historical data trend for Sirona Biochem's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Scaled Net Operating Assets Chart

Sirona Biochem Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.06

-0.01

0.21

-0.70

Sirona Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.07	-0.20	0.02	-0.82	-0.54

Competitive Comparison of Sirona Biochem's Scaled Net Operating Assets

For the Biotechnology subindustry, Sirona Biochem's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sirona Biochem's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's Scaled Net Operating Assets falls into.

Sirona Biochem Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sirona Biochem's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Oct. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Oct. 2023 )
=	(Operating Assets (A: Oct. 2023 )	-	Operating Liabilities (A: Oct. 2023 ))	/	Total Assets (A: Oct. 2022 )
=	(0.461	-	1.36)	/	1.291
=	-0.70

where

	Operating Assets		(A: Oct. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1.032	-	0.571
=	0.461

	Operating Liabilities		(A: Oct. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.543	-	1.539	-	0.644
=	1.36

Sirona Biochem's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jan. 2024 )
=	(Operating Assets (Q: Jan. 2024 )	-	Operating Liabilities (Q: Jan. 2024 ))	/	Total Assets (Q: Oct. 2023 )
=	(0.589	-	1.146)	/	1.032
=	-0.54

where

	Operating Assets		(Q: Jan. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.701	-	0.112
=	0.589

	Operating Liabilities		(Q: Jan. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.493	-	1.556	-	0.791
=	1.146

Sirona Biochem Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirona Biochem (TSXV:SBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (TSXV:SBM) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

SRBCF:USA ZSB:Germany

Address

C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3

Website

https://www.sironabiochem.com

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Executives

Howard Jarman Verrico

Director, Senior Officer